Cargando…

Pricing and reimbursement of novel oncology drugs in Sweden

Detalles Bibliográficos
Autores principales: Haglund, Mattias, Miller, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865793/
https://www.ncbi.nlm.nih.gov/pubmed/27226841
http://dx.doi.org/10.3402/jmahp.v2.25925
_version_ 1782431834438631424
author Haglund, Mattias
Miller, Eric
author_facet Haglund, Mattias
Miller, Eric
author_sort Haglund, Mattias
collection PubMed
description
format Online
Article
Text
id pubmed-4865793
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-48657932016-05-25 Pricing and reimbursement of novel oncology drugs in Sweden Haglund, Mattias Miller, Eric J Mark Access Health Policy Letter to the Editor Co-Action Publishing 2014-12-09 /pmc/articles/PMC4865793/ /pubmed/27226841 http://dx.doi.org/10.3402/jmahp.v2.25925 Text en © 2014 Mattias Haglund and Eric Miller http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Haglund, Mattias
Miller, Eric
Pricing and reimbursement of novel oncology drugs in Sweden
title Pricing and reimbursement of novel oncology drugs in Sweden
title_full Pricing and reimbursement of novel oncology drugs in Sweden
title_fullStr Pricing and reimbursement of novel oncology drugs in Sweden
title_full_unstemmed Pricing and reimbursement of novel oncology drugs in Sweden
title_short Pricing and reimbursement of novel oncology drugs in Sweden
title_sort pricing and reimbursement of novel oncology drugs in sweden
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865793/
https://www.ncbi.nlm.nih.gov/pubmed/27226841
http://dx.doi.org/10.3402/jmahp.v2.25925
work_keys_str_mv AT haglundmattias pricingandreimbursementofnoveloncologydrugsinsweden
AT millereric pricingandreimbursementofnoveloncologydrugsinsweden